The leader in know how and know why in oncology
We leverage provider and payer relationships, oncology experience and proprietary analytics to deliver actionable insights that drive successful market access.
Featured Insights
IDNs’ Numerous Strategies and Tools to Manage High-Cost Drugs
Welcome to the May 2024 edition of our Monthly Insight Series. This month we’re exploring the new tools IDNs have deployed to monitor high-cost drugs. This is a preview of findings from our 2024 IDN Oncology Trend Survey, coming at the end of May.
Read More
Article
Following the Money: Rx Revenues Underpin Community Oncology Business Models
Welcome to the April 2024 edition of our Monthly Insight Series. This month we’re looking at community oncology practices’ reliance on buy-and-bill drug revenues.
Lee Blansett
Article
IDN Financial Incentives: Impact on Treatment Prices?
Navigating IDNs requires understanding their financial drivers, revenue streams, and cost management. Here, we look at IDNs' key financial aspects, such as revenue optimization strategies, and examine the potential effects of site-neutral payment reforms.
Emma Bijesse
Article
Provider Economics Drive Oncologist Consolidation
Welcome to the March 2024 edition of our Monthly Insight Series. This month we examine the trend of oncologists consolidating into IDNs and network aggregators.
Taylor Crutison
The HMP Market Access Insights team helps us understand the interconnectivity between our major customer segments on really important issues and lead us toward better planning and business decisions.
Our Team
Lee Blansett
Executive Vice President
Cindy Chen
Head of Data Analytics
Chris Van Denburg
Director
Emma Bijesse
Director
Upcoming Events
31 May
27 Jun
06 Sep
Insights to Access
Our podcast featuring interviews with experts in the oncology management space.
